(Q46640882)

23 December 2017

title

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma (English)

1 reference

23 December 2017

main subject

patient

0 references

author

Athanasios Dimopoulos

7

1 reference

23 December 2017

author name string

L A Moulopoulos

1

1 reference

23 December 2017

D Gika

2

1 reference

23 December 2017

A Anagnostopoulos

3

1 reference

23 December 2017

K Delasalle

4

1 reference

23 December 2017

D Weber

5

1 reference

23 December 2017

R Alexanian

6

1 reference

23 December 2017

publication date

8 August 2005

1 reference

23 December 2017

published in

Annals of Oncology

1 reference

23 December 2017

volume

16

1 reference

23 December 2017

issue

11

1 reference

23 December 2017

page(s)

1824-1828

1 reference

23 December 2017

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Imaging of myeloma bone disease--implications for staging, prognosis and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

VAD-based regimens as primary treatment for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Multiple myeloma: MR patterns of response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI362

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI362

1 reference

23 December 2017

1 reference

23 December 2017